Feedback / Questions
amilomotide (CAD106) - Novartis
Q3 2012 Results
(Novartis)
-
Oct 25, 2012 -
Anticipated filing for Alzheimer's disease in 2016 or later
Anticipated regulatory
•
Alzheimer's Disease
http://www.larvolonline.com/tlg/ccdb/NovartisQ32012ResultsOct252012.pdf
Oct 25, 2012
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.